-
The influence of AHR on immune and tissue biology. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-06 Brigitta Stockinger,Oscar E Diaz,Emma Wincent
The aryl hydrocarbon receptor is a ligand dependent transcription factor which functions as an environmental sensor. Originally discovered as the sensor for man made pollutants such as 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) it has recently gained prominence as an important mediator for environmental triggers via the diet or microbiota which influences many physiological functions in different cell
-
Next generation of "magic bullets", solutions from the microbial pangenome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-06 Vega Masignani,Rino Rappuoli,Mariagrazia Pizza
-
Can we manipulate the ovary's own metabolism to protect it from chemotherapy-induced damage? EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-03 Adomas Liugaila,Agnes Stefansdottir,Norah Spears
-
The gray boundaries of aberrant shortening of the cellular timekeepers' edges. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-28 Guillermo Guenechea,Nestor W Meza
-
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-28 Hemanth Tummala,Amanda J Walne,Mohsin Badat,Manthan Patel,Abigail M Walne,Jenna Alnajar,Chi Ching Chow,Ibtehal Albursan,Jennifer M Frost,David Ballard,Sally Killick,Peter Szitányi,Anne M Kelly,Manoj Raghavan,Corrina Powell,Reinier Raymakers,Tony Todd,Elpis Mantadakis,Sophia Polychronopoulou,Nikolas Pontikos,Tianyi Liao,Pradeep Madapura,Upal Hossain,Tom Vulliamy,Inderjeet Dokal
Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome, caused by genetic mutations that principally affect telomere biology. Approximately 35% of cases remain uncharacterised at the genetic level. To explore the genetic landscape, we conducted genetic studies on a large collection of clinically diagnosed cases of DC as well as cases exhibiting features resembling DC, referred
-
Human breast tissue engineering in health and disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-23 Maj-Britt Buchholz,Demi I Scheerman,Riccardo Levato,Ellen J Wehrens,Anne C Rios
The human mammary gland represents a highly organized and dynamic tissue, uniquely characterized by postnatal developmental cycles. During pregnancy and lactation, it undergoes extensive hormone-stimulated architectural remodeling, culminating in the formation of specialized structures for milk production to nourish offspring. Moreover, it carries significant health implications, due to the high prevalence
-
Novel immunotherapeutics against LGR5 to target multiple cancer types. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-21 Hung-Chang Chen,Nico Mueller,Katherine Stott,Chrysa Kapeni,Eilidh Rivers,Carolin M Sauer,Flavio Beke,Stephen J Walsh,Nicola Ashman,Louise O'Brien,Amir Rafati Fard,Arman Godsinia,Changtai Li,Fadwa Joud,Olivier Giger,Inti Zlobec,Ioana Olan,Sarah J Aitken,Matthew Hoare,Richard Mair,Eva Serrao,James D Brenton,Alicia Garcia-Gimenez,Simon E Richardson,Brian Huntly,David R Spring,Mikkel-Ole Skjoedt,Karsten
We have developed and validated a highly specific, versatile antibody to the extracellular domain of human LGR5 (α-LGR5). α-LGR5 detects LGR5 overexpression in >90% of colorectal cancer (CRC), hepatocellular carcinoma (HCC) and pre-B-ALL tumour cells and was used to generate an Antibody-Drug Conjugate (α-LGR5-ADC), Bispecific T-cell Engager (α-LGR5-BiTE) and Chimeric Antigen Receptor (α-LGR5-CAR).
-
Fertility protection during chemotherapy treatment by boosting the NAD(P)+ metabolome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-21 Wing-Hong Jonathan Ho,Maria B Marinova,Dave R Listijono,Michael J Bertoldo,Dulama Richani,Lynn-Jee Kim,Amelia Brown,Angelique H Riepsamen,Safaa Cabot,Emily R Frost,Sonia Bustamante,Ling Zhong,Kaisa Selesniemi,Derek Wong,Romanthi Madawala,Maria Marchante,Dale M Goss,Catherine Li,Toshiyuki Araki,David J Livingston,Nigel Turner,David A Sinclair,Kirsty A Walters,Hayden A Homer,Robert B Gilchrist,Lindsay
Chemotherapy induced ovarian failure and infertility is an important concern in female cancer patients of reproductive age or younger, and non-invasive, pharmacological approaches to maintain ovarian function are urgently needed. Given the role of reduced nicotinamide adenine dinucleotide phosphate (NADPH) as an essential cofactor for drug detoxification, we sought to test whether boosting the NAD(P)+
-
Restoration of defective oxidative phosphorylation to a subset of neurons prevents mitochondrial encephalopathy. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-21 Brittni R Walker,Lise-Michelle Theard,Milena Pinto,Monica Rodriguez-Silva,Sandra R Bacman,Carlos T Moraes
Oxidative Phosphorylation (OXPHOS) defects can cause severe encephalopathies and no effective treatment exists for these disorders. To assess the ability of gene replacement to prevent disease progression, we subjected two different CNS-deficient mouse models (Ndufs3/complex I or Cox10/complex IV conditional knockouts) to gene therapy. We used retro-orbitally injected AAV-PHP.eB to deliver the missing
-
Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-20 Yue Wang,Hanbing Wang,Tao Shi,Xueru Song,Xin Zhang,Yue Zhang,Xuan Wang,Keying Che,Yuting Luo,Lixia Yu,Baorui Liu,Jia Wei
The CLDN18-ARHGAP fusion gene is an oncogenic driver newly discovered in gastric cancer. It was detected in 9% (8/87) of gastric cancer patients in our center. An immunogenic peptide specifically targeting CLDN18-ARHGAP fusion gene was generated to induce neoantigen-reactive T cells, which was proved to have specific and robust anti-tumor capacity both in in vitro coculture models and in vivo xenograft
-
An enhanced intracellular delivery platform based on a distant diphtheria toxin homolog that evades pre-existing antitoxin antibodies. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-19 Shivneet K Gill,Seiji N Sugiman-Marangos,Greg L Beilhartz,Elizabeth Mei,Mikko Taipale,Roman A Melnyk
Targeted intracellular delivery of therapeutic proteins remains a significant unmet challenge in biotechnology. A promising approach is to leverage the intrinsic capabilities of bacterial toxins like diphtheria toxin (DT) to deliver a potent cytotoxic enzyme into cells with an associated membrane translocation moiety. Despite showing promising clinical efficacy, widespread deployment of DT-based therapeutics
-
Histidine-rich glycoprotein modulates neutrophils and thrombolysis-associated hemorrhagic transformation. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-15 Wei Jiang,Yuexin Zhao,Rongrong Liu,Bohao Zhang,Yuhan Xie,Bin Gao,Kaibin Shi,Ming Zou,Dongmei Jia,Jiayue Ding,Xiaowei Hu,Yanli Duan,Ranran Han,DeRen Huang,Luc Van Kaer,Fu-Dong Shi
Intravenous thrombolysis using recombinant tissue plasminogen activator (tPA) remains the primary treatment for patients with acute ischemic stroke (AIS). However, the mechanism of tPA-related hemorrhagic transformation (HT) remains poorly understood. Elevation of histidine-rich glycoprotein (HRG) expression was detected by nano-liquid chromatography tandem mass spectrometry at 1 h following tPA infusion
-
Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-09 Peiyong Guan,Jianfeng Chen,Chengqiang Mo,Tomoya Fukawa,Chao Zhang,Xiuyu Cai,Mei Li,Jing Han Hong,Jason Yongsheng Chan,Cedric Chuan Young Ng,Jing Yi Lee,Suet Far Wong,Wei Liu,Xian Zeng,Peili Wang,Rong Xiao,Vikneswari Rajasegaran,Swe Swe Myint,Abner Ming Sun Lim,Joe Poh Sheng Yeong,Puay Hoon Tan,Choon Kiat Ong,Tao Xu,Yiqing Du,Fan Bai,Xin Yao,Bin Tean Teh,Jing Tan
Collecting duct carcinoma (CDC) is an aggressive rare subtype of kidney cancer with unmet clinical needs. Little is known about its underlying molecular alterations and etiology, primarily due to its rarity, and lack of preclinical models. This study aims to comprehensively characterize molecular alterations in CDC and identify its therapeutic vulnerabilities. Through whole-exome and transcriptome
-
Inhibition of GSK3α,β rescues cognitive phenotypes in a preclinical mouse model of CTNNB1 syndrome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-05 Jonathan M Alexander,Leeanne Vazquez-Ramirez,Crystal Lin,Pantelis Antonoudiou,Jamie Maguire,Florence Wagner,Michele H Jacob
CTNNB1 syndrome is a rare monogenetic disorder caused by CTNNB1 de novo pathogenic heterozygous loss-of-function variants that result in cognitive and motor disabilities. Treatment is currently lacking; our study addresses this critical need. CTNNB1 encodes β-catenin which is essential for normal brain function via its dual roles in cadherin-based synaptic adhesion complexes and canonical Wnt signal
-
The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-05 Jinhai Deng,Teng Pan,Dan Wang,Yourae Hong,Zaoqu Liu,Xingang Zhou,Zhengwen An,Lifeng Li,Giovanna Alfano,Gang Li,Luigi Dolcetti,Rachel Evans,Jose M Vicencio,Petra Vlckova,Yue Chen,James Monypenny,Camila Araujo De Carvalho Gomes,Gregory Weitsman,Kenrick Ng,Caitlin McCarthy,Xiaoping Yang,Zedong Hu,Joanna C Porter,Christopher J Tape,Mingzhu Yin,Fengxiang Wei,Manuel Rodriguez-Justo,Jin Zhang,Sabine Tejpar
Chemotherapy, the standard of care treatment for cancer patients with advanced disease, has been increasingly recognized to activate host immune responses to produce durable outcomes. Here, in colorectal adenocarcinoma (CRC) we identify oxaliplatin-induced Thioredoxin-Interacting Protein (TXNIP), a MondoA-dependent tumor suppressor gene, as a negative regulator of Growth/Differentiation Factor 15 (GDF15)
-
Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-31 Hong Wang,Huizi Sun,Jie Huang,Zhenhua Zhang,Guodi Cai,Chaofan Wang,Kai Xiao,Xiaofeng Xiong,Jian Zhang,Peiqing Liu,Xiaoyun Lu,Weineng Feng,Junjian Wang
Small-cell lung cancer (SCLC) is the most aggressive and lethal type of lung cancer, characterized by limited treatment options, early and frequent metastasis. However, the determinants of metastasis in SCLC are poorly defined. Here, we show that estrogen-related receptor gamma (ERRγ) is overexpressed in metastatic SCLC tumors, and is positively associated with SCLC progression. ERRγ functions as an
-
The RhoB p.S73F mutation leads to cerebral palsy through dysregulation of lipid homeostasis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-30 Xinyu Wu,Ruonan Liu,Zhongtian Zhang,Jie Yang,Xin Liu,Liqiang Jiang,Mengmeng Fang,Shoutang Wang,Liangxue Lai,Yuning Song,Zhanjun Li
Cerebral palsy (CP) is a prevalent neurological disorder that imposes a significant burden on children, families, and society worldwide. Recently, the RhoB p.S73F mutation was identified as a de novo mutation associated with CP. However, the mechanism by which the RhoB p.S73F mutation causes CP is currently unclear. In this study, rabbit models were generated to mimic the human RhoB p.S73F mutation
-
"Cruising together"-ASC specks and SAA, a perfect match in chronic inflammation. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-30 Salie Maasewerd,Bernardo Simoes Franklin
-
The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-30 Marco Losa,Marc Emmenegger,Pierre De Rossi,Patrick M Schürch,Tetiana Serdiuk,Niccolò Pengo,Danaëlle Capron,Dimitri Bieli,Niklas Bargenda,Niels J Rupp,Manfredi C Carta,Karl J Frontzek,Veronika Lysenko,Regina R Reimann,Petra Schwarz,Mario Nuvolone,Gunilla T Westermark,K Peter R Nilsson,Magdalini Polymenidou,Alexandre Pa Theocharides,Simone Hornemann,Paola Picotti,Adriano Aguzzi
Extracellularly released molecular inflammasome assemblies -ASC specks- cross-seed Aβ amyloid in Alzheimer's disease. Here we show that ASC governs the extent of inflammation-induced amyloid A (AA) amyloidosis, a systemic disease caused by the aggregation and peripheral deposition of the acute-phase reactant serum amyloid A (SAA) in chronic inflammatory conditions. Using super-resolution microscopy
-
Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-26 Matthew Hunt,Nuoqi Wang,Naricha Pupinyo,Philip Curman,Monica Torres,William Jebril,Maria Chatzinikolaou,Julie Lorent,Gilad Silberberg,Ritu Bansal,Teresa Burner,Jing Zhou,Susanne Kimeswenger,Wolfram Hoetzenecker,Keith Choate,Etty Bachar-Wikstrom,Jakob D Wikstrom
Darier disease (DD) is a rare severe acantholytic skin disease caused by mutations in the ATP2A2 gene that encodes for the sarco/endoplasmic reticulum calcium ATPase isoform 2 (SERCA2). SERCA2 maintains endoplasmic reticulum calcium homeostasis by pumping calcium into the ER, critical for regulating cellular calcium dynamics and cellular function. To date, there is no treatment that specifically targets
-
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-19 Luisa Chocarro,Ester Blanco,Leticia Fernandez-Rubio,Maider Garnica,Miren Zuazo,Maria Jesus Garcia,Ana Bocanegra,Miriam Echaide,Colette Johnston,Carolyn J Edwards,James Legg,Andrew J Pierce,Hugo Arasanz,Gonzalo Fernandez-Hinojal,Ruth Vera,Karina Ausin,Enrique Santamaria,Joaquin Fernandez-Irigoyen,Grazyna Kochan,David Escors
Many cancer patients do not benefit from PD-L1/PD-1 blockade immunotherapies. PD-1 and LAG-3 co-upregulation in T-cells is one of the major mechanisms of resistance by establishing a highly dysfunctional state in T-cells. To identify shared features associated to PD-1/LAG-3 dysfunctionality in human cancers and T-cells, multiomic expression profiles were obtained for all TCGA cancers immune infiltrates
-
LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-19 Jing Wang,Qiyao Chai,Zehui Lei,Yiru Wang,Jiehua He,Pupu Ge,Zhe Lu,Lihua Qiang,Dongdong Zhao,Shanshan Yu,Changgen Qiu,Yanzhao Zhong,Bing-Xi Li,Lingqiang Zhang,Yu Pang,George Fu Gao,Cui Hua Liu
Chronic infections, including Mycobacterium tuberculosis (Mtb)-caused tuberculosis (TB), can induce host immune exhaustion. However, the key checkpoint molecules involved in this process and the underlying regulatory mechanisms remain largely undefined, which impede the application of checkpoint-based immunotherapy in infectious diseases. Here, through adopting time-of-flight mass cytometry and transcriptional
-
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-15 Jeremy Rich,Melanie Bennaroch,Laura Notel,Polina Patalakh,Julien Alberola,Fayez Issa,Paule Opolon,Olivia Bawa,Windy Rondof,Antonin Marchais,Philippe Dessen,Guillaume Meurice,Morgane Le-Gall,Melanie Polrot,Karine Ser-Le Roux,Kamel Mamchaoui,Nathalie Droin,Hana Raslova,Pascal Maire,Birgit Geoerger,Iryna Pirozhkova
We have recently identified the uncharacterized ZNF555 protein as a component of a productive complex involved in the morbid function of the 4qA locus in facioscapulohumeral dystrophy. Subsequently named DiPRO1 (Death, Differentiation, and PROliferation related PROtein 1), our study provides substantial evidence of its role in the differentiation and proliferation of human myoblasts. DiPRO1 operates
-
Immune-enhancing neutrophils reprogrammed by subclinical low-dose endotoxin in cancer treatment. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-15 Yao Zhang,Christina Lee,Shuo Geng,Jing Wang,Udipta Bohara,Jacqueline Hou,Ziyue Yi,Liwu Li
Despite the re-emergence of the pioneering "Coley's toxin" concept in anti-cancer immune therapies highlighted by check-point inhibitors and CAR-T approaches, fundamental mechanisms responsible for the immune-enhancing efficacy of low-dose "Coley's toxin" remain poorly understood. This study examines the novel reprogramming of immune-enhancing neutrophils by super-low dose endotoxin conducive for anti-cancer
-
In vitro and in vivo inhibition of the host TRPC4 channel attenuates Zika virus infection. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-15 Xingjuan Chen,Yunzheng Yan,Zhiqiang Liu,Shaokang Yang,Wei Li,Zhuang Wang,Mengyuan Wang,Juan Guo,Zhenyang Li,Weiyan Zhu,Jingjing Yang,Jiye Yin,Qingsong Dai,Yuexiang Li,Cui Wang,Lei Zhao,Xiaotong Yang,Xiaojia Guo,Ling Leng,Jiaxi Xu,Alexander G Obukhov,Ruiyuan Cao,Wu Zhong
Zika virus (ZIKV) infection may lead to severe neurological consequences, including seizures, and early infancy death. However, the involved mechanisms are still largely unknown. TRPC channels play an important role in regulating nervous system excitability and are implicated in seizure development. We investigated whether TRPCs might be involved in the pathogenesis of ZIKV infection. We found that
-
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-08 Alexander Seidinger,Richard Roberts,Yan Bai,Marion Müller,Eva Pfeil,Michaela Matthey,Sarah Rieck,Judith Alenfelder,Gabriele M König,Alexander Pfeifer,Evi Kostenis,Anna Klinke,Bernd K Fleischmann,Daniela Wenzel
Pulmonary arterial hypertension (PAH) is a life-threatening disease with limited survival. Herein, we propose the pharmacological inhibition of Gq proteins as a novel concept to counteract pulmonary vasoconstriction and proliferation/migration of pulmonary artery smooth muscle cells (PASMCs) in PAH. We demonstrate that the specific pan-Gq inhibitor FR900359 (FR) induced a strong vasorelaxation in large
-
Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-08 Ibrahim Hawwari,Lukas Rossnagel,Nathalia Rosero,Salie Maasewerd,Matilde B Vasconcelos,Marius Jentzsch,Agnieszka Demczuk,Lino L Teichmann,Lisa Meffert,Damien Bertheloot,Lucas S Ribeiro,Sebastian Kallabis,Felix Meissner,Moshe Arditi,Asli E Atici,Magali Noval Rivas,Bernardo S Franklin
In humans, blood Classical CD14+ monocytes contribute to host defense by secreting large amounts of pro-inflammatory cytokines. Their aberrant activity causes hyper-inflammation and life-threatening cytokine storms, while dysfunctional monocytes are associated with 'immunoparalysis', a state of immune hypo responsiveness and reduced pro-inflammatory gene expression, predisposing individuals to opportunistic
-
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-02 Yifan Tai,Angela Chow,Seoyoung Han,Courtney Coker,Wanchao Ma,Yifan Gu,Valeria Estrada Navarro,Manoj Kandpal,Hanina Hibshoosh,Kevin Kalinsky,Katia Manova-Todorova,Anton Safonov,Elaine M Walsh,Mark Robson,Larry Norton,Richard Baer,Taha Merghoub,Anup K Biswas,Swarnali Acharyya
Acquired resistance to PARP inhibitors (PARPi) remains a treatment challenge for BRCA1/2-mutant breast cancer that drastically shortens patient survival. Although several resistance mechanisms have been identified, none have been successfully targeted in the clinic. Using new PARPi-resistance models of Brca1- and Bard1-mutant breast cancer generated in-vivo, we identified FLT1 (VEGFR1) as a driver
-
Author Correction: Mediators of necroptosis: from cell death to metabolic regulation. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-01 Xiaoqin Wu,Laura E Nagy,Jérémie Gautheron
-
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-26 Nicla Lorito,Angela Subbiani,Alfredo Smiriglia,Marina Bacci,Francesca Bonechi,Laura Tronci,Elisabetta Romano,Alessia Corrado,Dario Livio Longo,Marta Iozzo,Luigi Ippolito,Giuseppina Comito,Elisa Giannoni,Icro Meattini,Alexandra Avgustinova,Paola Chiarugi,Angela Bachi,Andrea Morandi
Triple-negative breast cancer (TNBC) has limited therapeutic options, is highly metastatic and characterized by early recurrence. Lipid metabolism is generally deregulated in TNBC and might reveal vulnerabilities to be targeted or used as biomarkers with clinical value. Ferroptosis is a type of cell death caused by iron-dependent lipid peroxidation which is facilitated by the presence of polyunsaturated
-
Minimally-invasive implantable device enhances brain cancer suppression. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-20 Xiaona Cao,Jie Li,Jinliang Ren,Jiajin Peng,Ruyue Zhong,Jiahao He,Ting Xu,Zhenhua Yu,Huawei Jin,Siqi Hao,Ruiwei Liu,Bingzhe Xu
Current brain tumor treatments are limited by the skull and BBB, leading to poor prognosis and short survival for glioma patients. We introduce a novel minimally-invasive brain tumor suppression (MIBTS) device combining personalized intracranial electric field therapy with in-situ chemotherapeutic coating. The core of our MIBTS technique is a wireless-ultrasound-powered, chip-sized, lightweight device
-
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-19 Mark Sementsov,Leonie Ott,Julian Kött,Alexander Sartori,Amelie Lusque,Sarah Degenhardt,Bertille Segier,Isabel Heidrich,Beate Volkmer,Rüdiger Greinert,Peter Mohr,Ronald Simon,Julia-Christina Stadler,Darryl Irwin,Claudia Koch,Antje Andreas,Benjamin Deitert,Verena Thewes,Andreas Trumpp,Andreas Schneeweiss,Yassine Belloum,Sven Peine,Harriett Wikman,Sabine Riethdorf,Stefan W Schneider,Christoffer Gebhardt
Circulating tumor DNA (ctDNA) is the cornerstone of liquid biopsy diagnostics, revealing clinically relevant genomic aberrations from blood of cancer patients. Genomic analysis of single circulating tumor cells (CTCs) could provide additional insights into intra-patient heterogeneity, but it requires whole-genome amplification (WGA) of DNA, which might introduce bias. Here, we describe a novel approach
-
Systemic immune challenge exacerbates neurodegeneration in a model of neurological lysosomal disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-18 Oriana Mandolfo,Helen Parker,Èlia Aguado,Yuko Ishikawa Learmonth,Ai Yin Liao,Claire O'Leary,Stuart Ellison,Gabriella Forte,Jessica Taylor,Shaun Wood,Rachel Searle,Rebecca J Holley,Hervé Boutin,Brian W Bigger
Mucopolysaccharidosis type IIIA (MPS IIIA) is a rare paediatric lysosomal storage disorder, caused by the progressive accumulation of heparan sulphate, resulting in neurocognitive decline and behavioural abnormalities. Anecdotal reports from paediatricians indicate a more severe neurodegeneration in MPS IIIA patients, following infection, suggesting inflammation as a potential driver of neuropathology
-
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-17 Majid Momeny,Mari Tienhaara,Mukund Sharma,Deepankar Chakroborty,Roosa Varjus,Iina Takala,Joni Merisaari,Artur Padzik,Andreas Vogt,Ilkka Paatero,Klaus Elenius,Teemu D Laajala,Kari J Kurppa,Jukka Westermarck
Despite clinical benefits of tyrosine kinase inhibitors (TKIs) in cancer, most tumors can reactivate proliferation under TKI therapy. Here we present transcriptional profiling of HER2+ breast cancer cells transitioning from dormant drug tolerant cells to re-proliferating cells under continuous HER2 inhibitor (HER2i) therapy. Focusing on phosphatases, expression of dual-specificity phosphatase DUSP6
-
Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-14 Partho Protim Adhikary,Temilolu Idowu,Zheng Tan,Christopher Hoang,Selina Shanta,Malti Dumbani,Leah Mappalakayil,Bhuwan Awasthi,Marcel Bermudez,January Weiner,Dieter Beule,Gerhard Wolber,Brent Dg Page,Sarah Hedtrich
Thymic stromal lymphopoietin (TSLP) is a key player in atopic diseases, which has sparked great interest in therapeutically targeting TSLP. Yet, no small-molecule TSLP inhibitors exist due to the challenges of disrupting the protein-protein interaction between TSLP and its receptor. Here, we report the development of small-molecule TSLP receptor inhibitors using virtual screening and docking of >1
-
Harnessing cholesterol uptake of malaria parasites for therapeutic applications. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-11 Merryn Fraser,Blake Curtis,Patrick Phillips,Patrick A Yates,Kwong Sum Lam,Otto Netzel,Giel G van Dooren,Alyssa Ingmundson,Kai Matuschewski,Malcolm D McLeod,Alexander G Maier
Parasites, such as the malaria parasite P. falciparum, are critically dependent on host nutrients. Interference with nutrient uptake can lead to parasite death and, therefore, serve as a successful treatment strategy. P. falciparum parasites cannot synthesise cholesterol, and instead source this lipid from the host. Here, we tested whether cholesterol uptake pathways could be 'hijacked' for optimal
-
Seeing is believing: a breakthrough to visualize necrosomes in the tissue. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-10 Chongbo Yang,J Magarian Blander
-
Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-06 Wing Yan So,Weiping Han
-
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson's patients. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-05 Laura de Boni,Amber Wallis,Aurelia Hays Watson,Alejandro Ruiz-Riquelme,Louise-Ann Leyland,Thomas Bourinaris,Naomi Hannaway,Ullrich Wüllner,Oliver Peters,Josef Priller,Björn H Falkenburger,Jens Wiltfang,Mathias Bähr,Inga Zerr,Katharina Bürger,Robert Perneczky,Stefan Teipel,Matthias Löhle,Wiebke Hermann,Björn-Hendrik Schott,Kathrin Brockmann,Annika Spottke,Katrin Haustein,Peter Breuer,Henry Houlden,Rimona
Synucleinopathies such as Parkinson's disease (PD) are defined by the accumulation and aggregation of the α-synuclein protein in neurons, glia and other tissues. We have previously shown that destabilization of α-synuclein tetramers is associated with familial PD due to SNCA mutations and demonstrated brain-region specific alterations of α-synuclein multimers in sporadic PD patients following the classical
-
A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-06-03 Bernadette Jeremiasse,Ravian L van Ineveld,Veerle Bok,Michiel Kleinnijenhuis,Sam de Blank,Maria Alieva,Hannah R Johnson,Esmée J van Vliet,Amber L Zeeman,Lianne M Wellens,Gerard Llibre-Palomar,Mario Barrera Román,Alessia Di Maggio,Johanna F Dekkers,Sabrina Oliveira,Alexander L Vahrmeijer,Jan J Molenaar,Marc Hwa Wijnen,Alida Fw van der Steeg,Ellen J Wehrens,Anne C Rios
Achieving complete tumor resection is challenging and can be improved by real-time fluorescence-guided surgery with molecular-targeted probes. However, pre-clinical identification and validation of probes presents a lengthy process that is traditionally performed in animal models and further hampered by inter- and intra-tumoral heterogeneity in target expression. To screen multiple probes at patient
-
Tubular insulin-induced gene 1 deficiency promotes NAD+ consumption and exacerbates kidney fibrosis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-05-28 Shumin Li,Jun Qin,Yingying Zhao,Jiali Wang,Songming Huang,Xiaowen Yu
Profibrotic proximal tubules (PT) were identified as a unique phenotype of proximal tubule cells (PTCs) in renal fibrosis by single-cell RNA sequencing (scRNA-seq). Controlling the process of renal fibrosis requires understanding how to manage the S1 subset's branch to the S3 subset rather than to the profibrotic PT subset. Insulin-induced gene 1 (Insig1) is one of the branch-dependent genes involved
-
Cell migration into the damaged brain mediated by increased cell adhesion. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-05-24 Jemima Becker,Francis Szele
-
Neuraminidase inhibition promotes the collective migration of neurons and recovery of brain function. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-05-24 Mami Matsumoto,Katsuyoshi Matsushita,Masaya Hane,Chentao Wen,Chihiro Kurematsu,Haruko Ota,Huy Bang Nguyen,Truc Quynh Thai,Vicente Herranz-Pérez,Masato Sawada,Koichi Fujimoto,José Manuel García-Verdugo,Koutarou D Kimura,Tatsunori Seki,Chihiro Sato,Nobuhiko Ohno,Kazunobu Sawamoto
In the injured brain, new neurons produced from endogenous neural stem cells form chains and migrate to injured areas and contribute to the regeneration of lost neurons. However, this endogenous regenerative capacity of the brain has not yet been leveraged for the treatment of brain injury. Here, we show that in healthy brain chains of migrating new neurons maintain unexpectedly large non-adherent
-
Immunogenicity and efficacy of CNA25 as a potential whole-cell vaccine against systemic candidiasis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-05-23 Satya Ranjan Sahu,Abinash Dutta,Doureradjou Peroumal,Premlata Kumari,Bhabasha Gyanadeep Utakalaja,Shraddheya Kumar Patel,Narottam Acharya
Disseminated fungal infections account for ~1.5 million deaths per year worldwide, and mortality may increase further due to a rise in the number of immunocompromised individuals and drug-resistance fungal species. Since an approved antifungal vaccine is yet to be available, this study explored the immunogenicity and vaccine efficacy of a DNA polymerase mutant strain of Candida albicans. CNA25 is a
-
Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-05-23 Laura Poupon-Bejuit,Amy Geard,Nathan Millicheap,Eridan Rocha-Ferreira,Henrik Hagberg,Claire Thornton,Ahad A Rahim
Hypoxic-ischaemic encephalopathy (HIE) arises from diminished blood flow and oxygen to the neonatal brain during labor, leading to infant mortality or severe brain damage, with a global incidence of 1.5 per 1000 live births. Glucagon-like Peptide 1 Receptor (GLP1-R) agonists, used in type 2 diabetes treatment, exhibit neuroprotective effects in various brain injury models, including HIE. In this study
-
A broadly applicable protein-polymer adjuvant system for antiviral vaccines. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-05-15 Caiqian Wang,Yuanyuan Geng,Haoran Wang,Zeheng Ren,Qingxiu Hou,An Fang,Qiong Wu,Liqin Wu,Xiujuan Shi,Ming Zhou,Zhen F Fu,Jonathan F Lovell,Honglin Jin,Ling Zhao
Although protein subunit vaccines generally have acceptable safety profiles with precise antigenic content, limited immunogenicity can lead to unsatisfactory humoral and cellular immunity and the need for vaccine adjuvants and delivery system. Herein, we assess a vaccine adjuvant system comprising Quillaja Saponaria-21(QS-21) and cobalt porphyrin polymeric micelles that enabling the display of His-tagged
-
Electron transport chain capacity expands yellow fever vaccine immunogenicity. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-05-14 Darren Zl Mok,Danny Jh Tng,Jia Xin Yee,Valerie Sy Chew,Christine Yl Tham,Justin Sg Ooi,Hwee Cheng Tan,Summer L Zhang,Lowell Z Lin,Wy Ching Ng,Lavanya Lakshmi Jeeva,Ramya Murugayee,Kelvin K-K Goh,Tze-Peng Lim,Liang Cui,Yin Bun Cheung,Eugenia Z Ong,Kuan Rong Chan,Eng Eong Ooi,Jenny G Low
Vaccination has successfully controlled several infectious diseases although better vaccines remain desirable. Host response to vaccination studies have identified correlates of vaccine immunogenicity that could be useful to guide development and selection of future vaccines. However, it remains unclear whether these findings represent mere statistical correlations or reflect functional associations
-
PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-05-10 Matilde Simoni,Chiara Menegazzi,Cristina Fracassi,Claudia C Biffi,Francesca Genova,Nazario Pio Tenace,Roberta Lucianò,Andrea Raimondi,Carlo Tacchetti,James Brugarolas,Davide Mazza,Rosa Bernardi
Clear-cell renal cell carcinoma (ccRCC), the major subtype of RCC, is frequently diagnosed at late/metastatic stage with 13% 5-year disease-free survival. Functional inactivation of the wild-type p53 protein is implicated in ccRCC therapy resistance, but the detailed mechanisms of p53 malfunction are still poorly characterized. Thus, a better understanding of the mechanisms of disease progression and
-
How to treat a "sweetheart" in mitochondrial cardiomyopathy. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-05-09 Hsin-Pin Lin,Derek P Narendra
-
GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-29 Michela Milani,Cesare Canepari,Simone Assanelli,Simone Merlin,Ester Borroni,Francesco Starinieri,Mauro Biffi,Fabio Russo,Anna Fabiano,Desirèe Zambroni,Andrea Annoni,Luigi Naldini,Antonia Follenzi,Alessio Cantore
Lentiviral vectors (LV) are efficient vehicles for in vivo gene delivery to the liver. LV integration into the chromatin of target cells ensures their transmission upon proliferation, thus allowing potentially life-long gene therapy following a single administration, even to young individuals. The glycoprotein of the vesicular stomatitis virus (VSV.G) is widely used to pseudotype LV, as it confers
-
CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-29 Yao Xiang,Jorge Mata-Garrido,Yuanji Fu,Christophe Desterke,Eric Batsché,Ahmed Hamaï,Christine Sedlik,Youssouf Sereme,David Skurnik,Abdelali Jalil,Rachel Onifarasoaniaina,Eric Frapy,Jean-Christophe Beche,Razack Alao,Eliane Piaggio,Laurence Arbibe,Yunhua Chang
As an important immune stimulator and modulator, IFNγ is crucial for gut homeostasis and its dysregulation links to diverse colon pathologies, such as colitis and colorectal cancer (CRC). Here, we demonstrated that the epigenetic regulator, CBX3 (also known as HP1γ) antagonizes IFNγ signaling in the colon epithelium by transcriptionally repressing two critical IFNγ-responsive genes: STAT1 and CD274
-
TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-26 Liman Qiu,Hongbing Ji,Kai Wang,Wenhan Liu,Qizhen Huang,Xinting Pan,Honghao Ye,Zhenli Li,Geng Chen,Xiaohua Xing,Xiuqing Dong,Ruijing Tang,Haipo Xu,Jingfeng Liu,Zhixiong Cai,Xiaolong Liu
Radiotherapy (RT) has been reported to induce abscopal effect in advanced hepatocellular carcinoma (HCC), but such phenomenon was only observed in sporadic cases. Here, we demonstrated that subcutaneous administration of Toll-like receptor 3 (TLR3) agonist poly(I:C) could strengthen the abscopal effect during RT through activating tumor cell ferroptosis signals in bilateral HCC subcutaneous tumor mouse
-
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-24 Alice Gambelli,Anna Nespolo,Gian Luca Rampioni Vinciguerra,Eliana Pivetta,Ilenia Pellarin,Milena S Nicoloso,Chiara Scapin,Linda Stefenatti,Ilenia Segatto,Andrea Favero,Sara D'Andrea,Maria Teresa Mucignat,Michele Bartoletti,Emilio Lucia,Monica Schiappacassi,Paola Spessotto,Vincenzo Canzonieri,Giorgio Giorda,Fabio Puglisi,Andrea Vecchione,Barbara Belletti,Maura Sonego,Gustavo Baldassarre
Platinum (PT)-resistant Epithelial Ovarian Cancer (EOC) grows as a metastatic disease, disseminating in the abdomen and pelvis. Very few options are available for PT-resistant EOC patients, and little is known about how the acquisition of PT-resistance mediates the increased spreading capabilities of EOC. Here, using isogenic PT-resistant cells, genetic and pharmacological approaches, and patient-derived
-
FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-08 Fenghua Bian,Chinmayee Goda,Guolun Wang,Ying-Wei Lan,Zicheng Deng,Wen Gao,Anusha Acharya,Abid A Reza,Jose Gomez-Arroyo,Nawal Merjaneh,Xiaomeng Ren,Jermaine Goveia,Peter Carmeliet,Vladimir V Kalinichenko,Tanya V Kalin
Cancer cells re-program normal lung endothelial cells (EC) into tumor-associated endothelial cells (TEC) that form leaky vessels supporting carcinogenesis. Transcriptional regulators that control the reprogramming of EC into TEC are poorly understood. We identified Forkhead box F1 (FOXF1) as a critical regulator of EC-to-TEC transition. FOXF1 was highly expressed in normal lung vasculature but was
-
A missense mutation in human INSC causes peripheral neuropathy. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-08 Jui-Yu Yeh,Hua-Chuan Chao,Cheng-Li Hong,Yu-Chien Hung,Fei-Yang Tzou,Cheng-Tsung Hsiao,Jeng-Lin Li,Wen-Jie Chen,Cheng-Ta Chou,Yu-Shuen Tsai,Yi-Chu Liao,Yu-Chun Lin,Suewei Lin,Shu-Yi Huang,Marina Kennerson,Yi-Chung Lee,Chih-Chiang Chan
PAR3/INSC/LGN form an evolutionarily conserved complex required for asymmetric cell division in the developing brain, but its post-developmental function and disease relevance in the peripheral nervous system (PNS) remains unknown. We mapped a new locus for axonal Charcot-Marie-Tooth disease (CMT2) and identified a missense mutation c.209 T > G (p.Met70Arg) in the INSC gene. Modeling the INSCM70R variant
-
Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-03 Simin Wang,Yangjie Xiong,Yuxiang Luo,Yanying Shen,Fengrui Zhang,Haoqi Lan,Yuzhi Pang,Xiaofang Wang,Xiaoqi Li,Xufen Zheng,Xiaojing Lu,Xiaoxiao Liu,Yumei Cheng,Tanwen Wu,Yue Dong,Yuan Lu,Jiujie Cui,Xiaona Jia,Sheng Yang,Liwei Wang,Yuexiang Wang
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with an overall 5-year survival rate of <12% due to the lack of effective treatments. Novel treatment strategies are urgently needed. Here, PKMYT1 is identified through genome-wide CRISPR screens as a non-mutant, genetic vulnerability of PDAC. Higher PKMYT1 expression levels indicate poor prognosis in PDAC patients. PKMYT1 ablation inhibits
-
Oxidized glutathione reverts carbapenem resistance in blaNDM-1-carrying Escherichia coli. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-02 Dongyang Ye,Xiaowei Li,Liang Zhao,Saiwa Liu,Xixi Jia,Zhinan Wang,Jingjing Du,Lirui Ge,Jianzhong Shen,Xi Xia
The emergence of drug-resistant Enterobacteriaceae carrying plasmid-mediated β-lactamase genes has become a significant threat to public health. Organisms in the Enterobacteriaceae family containing New Delhi metallo-β-lactamase‑1 (NDM-1) and its variants, which are capable of hydrolyzing nearly all β-lactam antibacterial agents, including carbapenems, are referred to as superbugs and distributed worldwide
-
Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-02 Jun Wu,Or Kakhlon,Miguel Weil,Alexander Lossos,Berge A Minassian
-
ImmunoPET imaging of Trop2 in patients with solid tumours. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-04-02 Wei Huang,You Zhang,Min Cao,Yanfei Wu,Feng Jiao,Zhaohui Chu,Xinyuan Zhou,Lianghua Li,Dongsheng Xu,Xinbing Pan,Yihui Guan,Gang Huang,Jianjun Liu,Fang Xie,Weijun Wei
Accurately predicting and selecting patients who can benefit from targeted or immunotherapy is crucial for precision therapy. Trophoblast cell surface antigen 2 (Trop2) has been extensively investigated as a pan-cancer biomarker expressed in various tumours and plays a crucial role in tumorigenesis through multiple signalling pathways. Our laboratory successfully developed two 68Ga-labelled nanobody
-
Gene therapy for deafness: are we there now? EMBO Mol. Med. (IF 9.0) Pub Date : 2024-03-25 Tobias Moser,Han Chen,Kathrin Kusch,Rüdiger Behr,Barbara Vona